Cittadine Andrew insider trades
Cittadine Andrew has filed 29 Form 4s with the SEC that we hold, all for Monopar Therapeutics (MNPR), as Chief Operating Officer. Across all of them we count 12 purchases worth $149.6K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 10,000 shares of Monopar Therapeutics worth $31.5K, dated 2022-11-15. The first filing on our record is dated 2021-07-02 and the latest 2026-10-02.
Monopar Therapeutics (MNPR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-14 | P, purchase reported on Form 4 | 6,053 | $18.2K | 2022-11-16 |
| 2022-11-15 | P, purchase reported on Form 4 | 10,000 | $31.5K | 2022-11-16 |
| 2024-05-29 | P, purchase reported on Form 4 | 12,000 | $7.7K | 2024-05-31 |
| 2024-05-30 | P, purchase reported on Form 4 | 12,000 | $7.7K | 2024-05-31 |
| 2024-05-31 | P, purchase reported on Form 4 | 12,000 | $7.7K | 2024-05-31 |
| 2024-06-03 | P, purchase reported on Form 4 | 12,000 | $9.1K | 2024-06-05 |
| 2024-06-04 | P, purchase reported on Form 4 | 12,000 | $9.4K | 2024-06-05 |
| 2024-06-13 | P, purchase reported on Form 4 | 12,000 | $10.9K | 2024-06-17 |
| 2024-06-14 | P, purchase reported on Form 4 | 12,000 | $11.2K | 2024-06-17 |
| 2024-06-17 | P, purchase reported on Form 4 | 12,000 | $10.8K | 2024-06-17 |
| 2024-06-18 | P, purchase reported on Form 4 | 12,000 | $10.3K | 2024-06-21 |
| 2024-06-20 | P, purchase reported on Form 4 | 20,508 | $15.2K | 2024-06-21 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1863624) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms